253 related articles for article (PubMed ID: 25234411)
1. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.
Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K
Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites.
Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K
J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668
[TBL] [Abstract][Full Text] [Related]
3. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
[TBL] [Abstract][Full Text] [Related]
4. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
6. The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites.
Miyake T; Iwatsuki K; Hirai Y; Yamamoto T; Hamada T; Fujii K; Imamura H; Morizane S
J Med Virol; 2020 Dec; 92(12):3689-3696. PubMed ID: 32255500
[TBL] [Abstract][Full Text] [Related]
7. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
[TBL] [Abstract][Full Text] [Related]
8. Risk of mortality in hydroa vacciniforme and hypersensitivity to mosquito bites.
Poligone B
Br J Dermatol; 2015 Jan; 172(1):5-6. PubMed ID: 25581582
[No Abstract] [Full Text] [Related]
9. Oculomucosal and gastrointestinal involvement in Epstein-Barr virus-associated hydroa vacciniforme.
Yamamoto T; Hirai Y; Miyake T; Yamasaki O; Morizane S; Iwatsuki K
Eur J Dermatol; 2012; 22(3):380-3. PubMed ID: 22361979
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis.
Asada H; Miyagawa S; Sumikawa Y; Yamaguchi Y; Itami S; Suguri S; Harada M; Tokura Y; Ishihara S; Ohshima S; Yoshikawa K
Arch Dermatol; 2003 Dec; 139(12):1601-7. PubMed ID: 14676078
[TBL] [Abstract][Full Text] [Related]
11. [Hypersensitivity to mosquito bites and hydroa vacciniforme].
Iwatsuki K; Yamamoto T; Tsuji K
Nihon Rinsho; 2006 Mar; 64 Suppl 3():657-61. PubMed ID: 16615554
[No Abstract] [Full Text] [Related]
12. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation.
Satoh M; Oyama N; Akiba H; Ohtsuka M; Iwatsuki K; Kaneko F
Eur J Dermatol; 2002; 12(4):381-4. PubMed ID: 12095889
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity to mosquito bites: A versatile Epstein-Barr virus disease with allergy, inflammation, and malignancy.
Yamada M; Ishikawa Y; Imadome KI
Allergol Int; 2021 Oct; 70(4):430-438. PubMed ID: 34334322
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
15. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
16. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
Chen CC; Chang KC; Medeiros LJ; Lee JY
J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
[TBL] [Abstract][Full Text] [Related]
17. [Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].
Umeki Y; Ikeda M; Nakahara W; Asako M; Matsuoka Y; Terakawa T; Matsunaga H; Tadokoro R; Sekiguchi M; Matsui T; Oka K; Higuchi K; Sawada A; Inoue M; Ueda S
Rinsho Ketsueki; 2023; 64(3):209-213. PubMed ID: 37019675
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.
Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ
Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
